CLST
Catalyst Bancorp, Inc.
There isn't enough reported data to score CLST yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CLST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
CLST's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CLST.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CLST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $13.68 | -22% |
| Current | 25x | $17.57 | — |
| Fair | 31x | $16.82 | -4.3% |
| Expensive | 126x | $69.15 | +294% |
Historical ranges are pointers, not guarantees.
CLST's PE is 25x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CLST Forward outlook
There aren't enough analyst estimates for CLST to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CLST Earnings Per Share
CLST and IREN do not have enough comparable growth data to identify a winner.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CLST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3M | +5% |
| Q1 2026 | $2.9M | -0.7% |
| Q4 2025 | $2.7M | -5.6% |
| Q3 2025 | $2.8M | -12% |
| Q2 2025 | $2.8M | -0.1% |
| Q4 2024 | $2.8M | +6.7% |
| Q3 2024 | $3.2M | +38% |
| Q2 2024 | $2.8M | +27% |
CLST's revenue fell from its 2021 peak and has held roughly level since: $3M last quarter, up 5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 23% | +0.3 points |
| Q1 2026 | 24% | -1.1 points |
| Q4 2025 | 21% | -6.7 points |
| Q3 2025 | 22% | +4.1 points |
| Q2 2025 | 23% | -0.4 points |
| Q1 2025 | 25% | N/A |
| Q4 2024 | 27% | +13 points |
| Q3 2024 | 18% | +9 points |
CLST has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over CLST on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CLST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $958K | -14% |
| Q1 2026 | $657K | +82% |
| Q4 2025 | $794K | +37% |
| Q3 2025 | $827K | +7.3% |
| Q2 2025 | $1.1M | -4.3% |
| Q4 2024 | $581K | -37% |
| Q3 2024 | $771K | +97% |
| Q4 2023 | $916K | +142% |
CLST has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CLST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +6K shares |
| 1 year | -0.6% | -22K shares |
| 3 years | -21% | -969K shares |
CLST has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $393,000 |
| Q1 2026 | $260,000 |
| Q4 2025 | $807,000 |
| Q3 2025 | $171,000 |
| Q2 2025 | $742,000 |
| Q1 2025 | $866,000 |
| Q4 2024 | $1.4M |
| Q3 2024 | $933,000 |
CLST spent $2M buying back its own shares over the past year, down 59% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CLST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -9.3x | Net Cash |
| Q1 2026 | -10.0x | Net Cash |
| Q4 2025 | -3.6x | Net Cash |
| Q3 2025 | -7.2x | Net Cash |
| Q2 2025 | -9.8x | Net Cash |
| Q1 2025 | -9.9x | Net Cash |
| Q4 2023 | 0.3x | Very low |
| Q3 2023 | -4.4x | Net Cash |
CLST has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CLST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 27.9 | Neutral |
CLST's weekly RSI is 58 (neutral) and its Stochastic is 28 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CLST PE vs Financial Services Sector
| Metric | CLST | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 13x | 96% above |
| PE % | 21 | 65 | 44 pts below |
CLST is trading at 25x earnings, a 96% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CLST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.2 | 2.4% above |
| 20 week MA | $17.2 | 2% above |
| 50 week MA | $16.5 | 6.6% above |
| 100 week MA | $14.4 | 22% above |
| 200 week MA | $13.0 | 35% above |
CLST has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CLST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $13.9 | $13.9 | +0.3% |
| 2022 | $13.9 | $12.8 | -8.1% |
| 2023 | $12.8 | $10.8 | -15% |
| 2024 | $10.8 | $11.7 | +7.9% |
| 2025 | $11.7 | $15.5 | +33% |
| 2026 YTD | $15.5 | $17.6 | +13% |
CLST has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.